Clamoxyl Long Acting 150 mg/ml Suspension for Injection

País: Regne Unit

Idioma: anglès

Font: VMD (Veterinary Medicines Directorate)

Compra'l ara

Descargar Fitxa tècnica (SPC)
03-01-2023

ingredients actius:

Amoxicillin

Disponible des:

Zoetis UK Limited

Codi ATC:

QJ01CA04

Designació comuna internacional (DCI):

Amoxicillin

formulario farmacéutico:

Suspension for injection

tipo de receta:

POM-V - Prescription Only Medicine – Veterinarian

Grupo terapéutico:

Cats, Dogs, Sheep

Área terapéutica:

Antimicrobial

Estat d'Autorització:

Authorized

Data d'autorització:

1998-01-28

Fitxa tècnica

                                Revised: April 2022
AN: 01524/2021
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Clamoxyl Long Acting 150 mg/ml Suspension for Injection
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
_Active ingredients:_
_mg/ml_
Amoxicillin
150
(As Amoxicillin trihydrate)
For a full list of excipients please see section 6.1
3.
PHARMACEUTICAL FORM
Suspension for injection.
White to off-white oily suspension.
4.
CLINICAL PARTICULARS
4.1 TARGET SPECIES
Sheep, dogs and cats
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
The product is a broad-spectrum semi-synthetic penicillin which is
bactericidal _in _
_vitro_ against a wide range of Gram-positive and Gram-negative
bacteria including
the following:
_Gram-negative: _
_Actinobacillus lignieresi; Bordetella bronchiseptica, Escherichia
coli _(non beta-
lactamase
producing
strains)_, _
Corynebacterium
spp.;
Fusobacterium
spp.;
Haemophilus spp.; Moraxella spp.; Pasteurella spp.; _Proteus mirabilis
_(non beta-
lactamase producing strains);_ _Salmonella spp.
_Gram-positive:_
_Bacillus anthracis; _Clostridium spp_.; Erysipelothrix rhusiopathiae;
_Streptococci;
Staphylococci (non beta-lactamase producing strains).
The product is suitable for the control of infections caused by
susceptible
organisms in sheep, dogs and cats where prolonged activity from a
single
injection is required. It may also be used to control secondary
bacterial invasion
in conditions where bacteria are not a primary cause of disease.
Revised: April 2022
AN: 01524/2021
Page 2 of 6
Particular indications for the product are:
1.
Alimentary tract infections, including enteritis
2.
Respiratory tract infections.
3.
Urogenital tract infections, including cystitis and metritis
4.
Skin and soft tissue infections, including wounds, abscesses, foot
infections, joint and navel ill.
5.
Prevention of post-operative infections by injection prior to surgery.
4.3 CONTRA-INDICATIONS
In common with all other penicillins, amoxicillin should not be used
orally or
parenterally in rabbits, g
                                
                                Llegiu el document complet
                                
                            

Cerqueu alertes relacionades amb aquest producte